Fellowship in Industry Program — Partner Therapeutics

This unique two-year, Boston-based fellowship program is a 50/50 split of medical affairs and clinical development with additional exposure to regulatory science in the first year. In the second year, the fellow can choose an area of focus within medical affairs or clinical development. The program will help prepare the fellow to become a well-rounded industry leader with a deep understanding of the importance of cross-functional partnership. This is one of the few programs in the country that balances the fellow’s long-term goals with institutional priorities in a setting where clinical development and medical affairs are highly integrated.

Activities at Partner Therapeutics

Medical Affairs

• Develop and maintain scientific expertise in therapeutic area(s) relevant to the company’s portfolio.
• Support the creation and review of scientific content, including slide decks, medical information letters, FAQs, and standard response documents.
• Participate in medical review of promotional and non-promotional materials to ensure scientific accuracy and regulatory compliance.
• Engage with cross-functional partners (regulatory, commercial, clinical operations) to provide medical and scientific insights.
• Respond to unsolicited medical information requests from healthcare professionals.
• Collaborate with field medical teams (MSLs) by preparing resources, training, and supporting scientific exchange initiatives.
• Contribute to scientific congress planning and execution, including booth activities, medical information dissemination, and competitive intelligence collection.
• Assist in generating real-world evidence and publications, including abstracts, posters, and manuscripts.

Clinical Development

• Assist in the development and management of cross-functional study and program timelines.
• Gain exposure to the design, implementation, and management of clinical trials.
• Gain an understanding of the regulations and guidelines that govern clinical trial conduct, including ICH Good Clinical Practice (GCP) and FDA IND requirements.
• Contribute to ongoing pharmacovigilance activities, including safety monitoring, adverse event reporting, and data review for ongoing studies.
• Support cross-functional study team meetings and clinical operations activities.
• Participate in interactions with clinical investigators, study sites, and contract research organizations (CROs).
• Collaborate on data analysis, interpretation of study results, and preparation of clinical study reports.
• Contribute to regulatory submissions and responses by providing clinical and scientific input.
• Monitor scientific and clinical landscapes to identify unmet medical needs and potential trial opportunities.

Fellowship Program Dates

The fellowship begins July 1, 2026 and ends June 30, 2028.